Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus

Схожие документы

• The parasitic worm-derived immunomodulator, ES-62 and its drug-like small molecule analogues exhibit therapeutic potential in a model of chronic asthma
  по: Coltherd, J. C., et al.
  Опубликовано: (2016)
• The Parasitic Worm Product ES-62 Targets Myeloid Differentiation Factor 88–Dependent Effector Mechanisms to Suppress Antinuclear Antibody Production and Proteinuria in MRL/lpr Mice
  по: Rodgers, David T, et al.
  Опубликовано: (2015)
• Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62
  по: Lumb, Felicity E., et al.
  Опубликовано: (2017)
• Testing small molecule analogues of the Acanthocheilonema viteae immunomodulator ES‐62 against clinically relevant allergens
  по: Janicova, L., et al.
  Опубликовано: (2016)
• Protection Against Arthritis by the Parasitic Worm Product ES-62, and Its Drug-Like Small Molecule Analogues, Is Associated With Inhibition of Osteoclastogenesis
  по: Doonan, James, et al.
  Опубликовано: (2018)